Pancreatic Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults who have been diagnosed with locally advanced pancreatic cancer (confirmed by a biopsy) and whose treating oncologist has determined they are suitable for combination chemotherapy.
Who may not be able to join:
- People who are pregnant.
- People whose pancreatic cancer has spread to other parts of the body (metastatic cancer).
- People who currently have another active cancer, unless it is a superficial skin cancer (squamous cell carcinoma of the skin) or a cancer that has not yet spread beyond where it started (in situ cancer).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Shahid Ahmed, MD, PhD, University of Saskatchewan
Phone: 3066122617
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
1 year progression free survival rate of patients with locally advanced pancreatic cancer who are treated with IRE and combination chemotherapy.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.